Search results for "Lineage markers"

showing 5 items of 5 documents

Telencephalic-olfactory bulb ventricle wall organization in Austrolebias charrua: Cytoarchitecture, proliferation dynamics, neurogenesis and migratio…

2016

Adult neurogenesis participates in fish olfaction sensitivity in response to environmental challenges. Therefore, we investigated if several populations of stem/progenitor cells that are retained in the olfactory bulbs (OB) may constitute different neurogenic niches that support growth and functional demands. By electron microscopy and combination cell proliferation and lineage markers, we found that the telencephalic ventricle wall (VW) at OB level of Austrolebias charrua fish presents three neurogenic niches (transitional 1, medial 2 and ventral 3). The main cellular types described in other vertebrate neurogenic niches were identified (transient amplifying cells, stem cells and migrating…

0301 basic medicineTelencephalonNeurogenesisBiology03 medical and health sciencesCyprinodontiformesNeuroblastCell MovementmedicineAnimalsCell LineageProgenitor cellCell ProliferationNeuronsCerebrumGeneral NeuroscienceCiliumLineage markersStem CellsNeurogenesisOlfactory BulbOlfactory bulbCell biology030104 developmental biologymedicine.anatomical_structureStem cellNeuroscienceNeuroscience
researchProduct

Role of the cellular prion protein in oligodendrocyte precursor cell proliferation and differentiation in the developing and adult mouse CNS

2012

There are numerous studies describing the signaling mechanisms that mediate oligodendrocyte precursor cell (OPC) proliferation and differentiation, although the contribution of the cellular prion protein (PrP c) to this process remains unclear. PrP c is a glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein involved in diverse cellular processes during the development and maturation of the mammalian central nervous system (CNS). Here we describe how PrP c influences oligodendrocyte proliferation in the developing and adult CNS. OPCs that lack PrP c proliferate more vigorously at the expense of a delay in differentiation, which correlates with changes in the expression of oligodendrocyt…

Central Nervous SystemTelencephalonMouseCellular differentiationanimal diseasesGene ExpressionHippocampusMice0302 clinical medicineNeural Stem CellsGene expressionMolecular Cell BiologyNeurobiology of Disease and RegenerationCell proliferationNeuronsCerebral CortexMice Knockout0303 health sciencesProliferació cel·lularMultidisciplinaryNeurogenesisQRCell DifferentiationAnimal ModelsNeural stem cell3. Good healthCell biologyOligodendrogliamedicine.anatomical_structureKnockout mouseMedicineFemaleBiologia del desenvolupamentCellular TypesCell DivisionResearch ArticlePrionsNeurogenesisScienceBiologyModels BiologicalCell Growth03 medical and health sciencesModel OrganismsDevelopmental NeuroscienceNeuroglial Developmentmental disordersDevelopmental biologymedicineAnimalsPrPC ProteinsBiology030304 developmental biologyCell ProliferationCell growthLineage markersMolecular DevelopmentOligodendrocytenervous system diseasesMice Inbred C57BLImmunologyOrganism Development030217 neurology & neurosurgeryDevelopmental BiologyNeuroscience
researchProduct

Blastic Plasmacytoid Dendritic Cell Neoplasm

2020

Clinical and biological presentation of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is depicted to highlight criteria that might alert physicians. Diagnosis of BPDCN is still challenging and requires (1) immunophenotyping of blood or bone marrow aspiration using several markers (CD4, CD56, HLA-DR, myeloid and lymphoid lineage markers) and should include pDC markers such as CD123, cTCL1, CD303, and CD304, and/or (2) pathologic analysis of cutaneous lesions, also with immunohistochemistry using markers specific to BPDCN.

Pathologymedicine.medical_specialtyMyeloidbusiness.industryLineage markersHematologyBlastic plasmacytoid dendritic cell neoplasm3. Good health03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureImmunophenotypingOncology030220 oncology & carcinogenesisMedicineImmunohistochemistryInterleukin-3 receptorBone marrowPresentation (obstetrics)business030215 immunologyHematology/Oncology Clinics of North America
researchProduct

A novel isolation technique and extended characte-rization of mesenchymal stem cells from human umbilical cord matrix: disclosing new potentials for …

2008

Settore BIO/16 - Anatomia Umanamesenchymal cells umbilical cord regenerative medicine immune regulation differentiation lineage markers
researchProduct

The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Imm…

2008

Abstract Acute myeloid leukemia (AML) is thought to arise from a rare putative ‘leukemic stem cell’ that is capable of self-renewal and formation of leukemic blasts. Serial xenotransplantation studies in immunodeficient mice have shown that this leukemia-initiating cell resides at very low numbers within CD34(high)-positive CD38-negative AML cells. Thus, immunotherapeutic approaches successfully eradicating this cell compartment should result in cure from disease. The objective of our study was to characterize the immune phenotype of the CD38-negative and CD38-positive subsets of primary CD34(high)-positive AML blasts ex vivo. We obtained therapeutic leukapheresis products from 17 AML patie…

biologyLineage markersImmunologyCD34hemic and immune systemsCell BiologyHematologyHuman leukocyte antigenmedicine.diseaseBiochemistryCD19Leukemiahemic and lymphatic diseasesbiology.proteinCancer researchmedicineCytotoxic T cellInterleukin-3 receptorCD8Blood
researchProduct